BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 21251634)

  • 21. Changing outcomes and treatment strategies for wire induced coronary perforations in the era of bivalirudin use.
    Kini AS; Rafael OC; Sarkar K; Rajdev S; Jakkula M; Mares AM; Kaplish D; Krishnan P; Kim MC; Sharma SK
    Catheter Cardiovasc Interv; 2009 Nov; 74(5):700-7. PubMed ID: 19496119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resolute Italian study in all comers: immediate and one-year outcomes.
    Romagnoli E; Godino C; Ielasi A; Gasparini G; Tzifos V; Sciahbasi A; Lioy E; Presbitero P; Colombo A; Sangiorgi G
    Catheter Cardiovasc Interv; 2012 Mar; 79(4):567-74. PubMed ID: 21805557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Bypass Angioplasty Revascularization in Type 1 and Type 2 Diabetes Study: 5-year follow-up of revascularization with percutaneous coronary intervention versus coronary artery bypass grafting in diabetic patients with multivessel disease.
    Kapur A; Bartolini D; Finlay MC; Qureshi AC; Flather M; Strange JW; Hall RJ
    J Cardiovasc Med (Hagerstown); 2010 Jan; 11(1):26-33. PubMed ID: 19797974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distal coronary perforation in patients with prior coronary artery bypass graft surgery: The importance of early treatment.
    Karatasakis A; Akhtar YN; Brilakis ES
    Cardiovasc Revasc Med; 2016 Sep; 17(6):412-7. PubMed ID: 27465517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coronary angioplasty, bypass surgery, and retransplantation in cardiac transplant patients with graft coronary disease.
    Musci M; Loebe M; Wellnhofer E; Meyer R; Pasic M; Hummel M; Bocksch W; Grauhan O; Weng Y; Hetzer R
    Thorac Cardiovasc Surg; 1998 Oct; 46(5):268-74. PubMed ID: 9885117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. "Incidence, clinical and angiographic characteristics, management and outcomes of coronary artery perforation at a high volume cardiac care center during percutaneous coronary intervention".
    Krishnegowda C; Puttegowda B; Krishnappa S; Ananthakrishna R; Mahadevappa NC; Siddegowda SK; Ramegowda RT; Manjunath CN
    Indian Heart J; 2020; 72(4):232-238. PubMed ID: 32861375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of the extent of coronary artery disease on outcomes after revascularization for unprotected left main coronary artery stenosis.
    Kim YH; Park DW; Kim WJ; Lee JY; Yun SC; Kang SJ; Lee SW; Lee CW; Hong MK; Park SW; Park SJ
    J Am Coll Cardiol; 2010 Jun; 55(23):2544-52. PubMed ID: 20513593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Very long-term results comparing a simple versus a complex stenting strategy in the treatment of coronary bifurcation lesions.
    Sheiban I; Infantino VA; Colombo F; Bollati M; Omedè P; Moretti C; Sciuto F; Siliquini R; Chiadò S; Trevi GP; Biondi-Zoccai G
    Catheter Cardiovasc Interv; 2009 Aug; 74(2):313-20. PubMed ID: 19496110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute and long-term outcomes after polytetrafluoroethylene or pericardium covered stenting for grade 3 coronary artery perforations: Insights from G3-CAP registry.
    Pavani M; Cerrato E; Latib A; Ryan N; Calcagno S; Rolfo C; Ugo F; Ielasi A; Escaned J; Tespili M; Conrotto F; Mancone M; Colombo A; Varbella F
    Catheter Cardiovasc Interv; 2018 Dec; 92(7):1247-1255. PubMed ID: 30244520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Covered stent implantation through a single 8-french guide catheter for the management of a distal coronary perforation.
    Sandoval Y; Lobo AS; Brilakis ES
    Catheter Cardiovasc Interv; 2017 Oct; 90(4):584-588. PubMed ID: 28303639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early and long-term results of percutaneous coronary intervention for unprotected left main trifurcation disease.
    Sheiban I; Gerasimou A; Bollati M; Biondi-Zoccai G; Sciuto F; Omedé P; Sillano D; Trevi GP; Moretti C
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):25-31. PubMed ID: 19089932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical outcome of patients with diabetes presenting with ST-elevation myocardial infarction and treated with concomitant use of glycoprotein IIb/IIIa inhibitors.
    Kralev S; Krause B; Papavassiliu T; Lang S; Haghi D; Kälsch T; Dempfle CE; Borggrefe M; Süselbeck T
    Cardiol J; 2009; 16(3):234-40. PubMed ID: 19437397
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of bivalirudin in patients receiving clopidogrel therapy after diagnostic angiography for percutaneous coronary intervention in acute coronary syndromes.
    Feldman DN; Minutello RM; Bergman G; Moussa I; Wong SC
    Catheter Cardiovasc Interv; 2010 Oct; 76(4):513-24. PubMed ID: 20882655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Percutaneous coronary intervention of unprotected left main coronary artery disease as culprit lesion in patients with acute myocardial infarction.
    Pappalardo A; Mamas MA; Imola F; Ramazzotti V; Manzoli A; Prati F; El-Omar M
    JACC Cardiovasc Interv; 2011 Jun; 4(6):618-26. PubMed ID: 21700247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and procedural predictors of suboptimal outcome after the treatment of drug-eluting stent restenosis in the unprotected distal left main stem: the Milan and New-Tokyo (MITO) registry.
    Takagi K; Ielasi A; Shannon J; Latib A; Godino C; Davidavicius G; Mussardo M; Ferrarello S; Figini F; Carlino M; Montorfano M; Chieffo A; Nakamura S; Colombo A
    Circ Cardiovasc Interv; 2012 Aug; 5(4):491-8. PubMed ID: 22851528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug-eluting stents and glycoprotein IIb/IIIa inhibitors in vessels at low anatomic risk: a retrospective analysis of previously published data from the Basel Stent Kosten Effektivitäts Trial.
    Jeger RV; Brunner-La Rocca HP; Hunziker PR; Tsakiris DA; Kaiser CA; Pfisterer ME;
    Clin Ther; 2009 Dec; 31(12):2886-93. PubMed ID: 20110027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successful deployment of polytetrafluoroethylene-covered stent to seal left internal mammary artery graft perforation due to guide catheter extension system.
    Ichimoto E; De Gregorio J
    Cardiovasc Revasc Med; 2016 Dec; 17(8):574-577. PubMed ID: 27394179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transradial versus transfemoral method of percutaneous coronary revascularization for unprotected left main coronary artery disease: comparison of procedural and late-term outcomes.
    Yang YJ; Kandzari DE; Gao Z; Xu B; Chen JL; Qiao SB; Li JJ; Qin XW; Yao M; Wu YJ; Yuan JQ; Chen J; Liu HB; Dai J; Chen T; Wang Y; Li W; Gao RL
    JACC Cardiovasc Interv; 2010 Oct; 3(10):1035-42. PubMed ID: 20965462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thin strut chrome-cobalt stent implantation for treatment of de-novo lesions in small coronary vessels: results of the RISICO Italian Registry (Registro Italiano Mini VISION nei piccolo Vasi) utilizing the Mini VISION coronary stent platform.
    Brambilla N; Morici N; Bedogni F; De Benedictis M; Scrocca I; Naldi M; Fiscella A; Prosperi F; Dominici M; Rebuzzi A; Colombo A; Sangiorgi GM;
    J Cardiovasc Med (Hagerstown); 2009 Nov; 10(11):852-8. PubMed ID: 19550353
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coronary artery perforation complicating percutaneous coronary intervention.
    Mirza AJ; Taha AY; Aldoori JS; Hawas JM; Hassan KW
    Asian Cardiovasc Thorac Ann; 2018 Feb; 26(2):101-106. PubMed ID: 29338301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.